SEC Form 4 · accession 0001225208-19-003892
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard R. DeLuca
Officer — EVP&Pres, Merck Animal Health
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 6:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 25, 2019 | A | 13,507 | $80.38 | A | 70,585 | D | |
| Common Stock - 401(k) PlanF3 | holding | — | — | — | 1,067 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distrubtion of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/16. Performance shares were paid out at 126 percent of target awards. Includes dividends accured over the three-year performance period ending December 31, 2018.
- F2Holdings include shares acquired in dividend reinvestment transactions.
- F3Includes shares acquired and dividends earned through January 8, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.